Millennium Pharmaceuticals, Inc. (now Takeda Pharmaceutical Company Limited)
Genetics Institute (acquired by Wyeth Research, now Pfizer)
Isabelle brings over 30 years of specialized contracts management and negotiation experience to Faber clients in the healthcare, biopharmaceutical, and high technology industries and is the founder of the firm’s contracts specialists group. She works with clients to develop efficient contracting processes and streamlined contract templates in the discovery, pre-clinical and clinical phases of development.
In the clinical trial setting, Isabelle helps clients resolve challenging issues such as changes of CROs during ongoing, multi-national clinical studies, transfers of studies among sponsors, and engagement of multiple sites in investigator-initiated studies. Her vast experience across wide-ranging types of companies in the industry—start ups, clinical stage companies, contract research organizations, consulting groups, and big pharma—gives her a uniquely well-rounded perspective and understanding of day-to-day transactions common in the biopharmaceutical industry. As a result of her deep knowledge, Isabelle is frequently invited to speak at industry conferences on topics ranging from clinical trial subject injury issues to international considerations when contracting for clinical trials abroad.
Millennium Pharmaceuticals (now Takeda)
Associate Director of Contracts Administration
Genetics Institute (now Pfizer)
In her role as contracts manager for Parexel International Isabelle negotiated service agreements with major pharmaceutical companies wanting to engage Parexel as a CRO. At Cytomed, she developed and implemented a contracts tracking and management system.